132 related articles for article (PubMed ID: 2443152)
1. Interferon and malignant disease.
Sikora K
Br J Clin Pract; 1986 Oct; 40(10):406-10. PubMed ID: 2443152
[No Abstract] [Full Text] [Related]
2. Interferons: basic research, clinical studies, and their support.
Friedman RM
Arch Pathol Lab Med; 1982 Jun; 106(6):259-60. PubMed ID: 6178383
[TBL] [Abstract][Full Text] [Related]
3. Interferon: reason for hope.
Warren B
Can Nurse; 1983 Feb; 79(2):15-6. PubMed ID: 6186360
[No Abstract] [Full Text] [Related]
4. Interferons and cancer: how the promise is being kept.
Borden EC
Interferon; 1983; 5():43-83. PubMed ID: 6202643
[No Abstract] [Full Text] [Related]
5. Current status of interferon therapy in oncology.
Roth MS; Foon KA
Prog Hematol; 1987; 15():19-38. PubMed ID: 2459731
[No Abstract] [Full Text] [Related]
6. The role of interferons in the treatment of malignant neoplasms.
Murren JR; Buzaid AC
Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
[TBL] [Abstract][Full Text] [Related]
7. Clinical trials with interferon in Japan.
Imanishi J; Kishida T
Tex Rep Biol Med; 1981-1982; 41():647-52. PubMed ID: 6189229
[No Abstract] [Full Text] [Related]
8. Interferon-new wonder drug or old laboratory curiosity?
Tannock GA
Med J Aust; 1981 Oct; 2(7):352-6. PubMed ID: 6170870
[No Abstract] [Full Text] [Related]
9. [Predictive factors of response to interferon in chronic hepatitis].
Forns X; Ampurdanés S
Gastroenterol Hepatol; 1995; 18(7):388-95. PubMed ID: 7553278
[No Abstract] [Full Text] [Related]
10. Interferons: in pursuit of the promise.
Borden EC
Prog Clin Biol Res; 1983; 132E():287-96. PubMed ID: 6196788
[No Abstract] [Full Text] [Related]
11. Interferons and cancer: the end of the beginning or the beginning of the end?
Priestman TJ
Clin Oncol; 1981 Dec; 7(4):271-4. PubMed ID: 6172229
[No Abstract] [Full Text] [Related]
12. Interferon clinical trials.
Cancer Nurs; 1980 Dec; 3(6):450. PubMed ID: 6159070
[No Abstract] [Full Text] [Related]
13. [On the use and mechanisms of action of Interferon as antitumour substances (author's transl)].
Busse E; Rose H; Flöth L
Radiobiol Radiother (Berl); 1980 Feb; 21(1):18-22. PubMed ID: 6162170
[No Abstract] [Full Text] [Related]
14. Prospects for the medical use of interferon in 1984.
Postic B; Arroyo JC
Henry Ford Hosp Med J; 1984; 32(2):116-22. PubMed ID: 6210270
[No Abstract] [Full Text] [Related]
15. Further studies on clinical trials of interferon in Japan.
Yamazaki S
Jpn J Med Sci Biol; 1984; 37(5-6):209-23. PubMed ID: 6085640
[No Abstract] [Full Text] [Related]
16. Biotherapy in clinical practice.
Figlin RA
Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
[TBL] [Abstract][Full Text] [Related]
17. Interferon in Michigan.
Rich J
Mich Med; 1981 Aug; 80(23):402. PubMed ID: 6167843
[No Abstract] [Full Text] [Related]
18. Interferon studies at the Wisconsin Clinical Cancer Center.
Buchanan-Davidson DJ
Wis Med J; 1980 Sep; 79(9):35. PubMed ID: 6158802
[No Abstract] [Full Text] [Related]
19. Interferon: an early evaluation.
McCredie KB; Moore MS
J Okla State Med Assoc; 1980 Sep; 73(9):325-8. PubMed ID: 6160226
[No Abstract] [Full Text] [Related]
20. [Interferon: a protein with antiviral, antiproliferative, immunoregulatory and antineoplastic properties].
Kirchner H; Beck J
Verh Dtsch Ges Inn Med; 1980; 86():496-502. PubMed ID: 6164176
[No Abstract] [Full Text] [Related]
[Next] [New Search]
